Churn in FDA’s in­spec­tion unit; Roche’s chang­ing of the guard; Il­lu­mi­na on de­fense; NASH be­liev­er finds new chal­lenge; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

We wel­comed two new mem­bers to the ed­i­to­r­i­al team last week: Jared Whit­lock joined as fea­tures ed­i­tor while Aayushi Prat­ap came on board as a news re­porter. You might have read some of Aayushi’s news sto­ries al­ready, and Jared put out his first End­points In Fo­cus piece this week, on Il­lu­mi­na’s co­nun­drum. It’s an in­ter­est­ing read — check it out be­low.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER